Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioAtla (BCAB) Enterprise Value (2020 - 2025)

BioAtla (BCAB) has 6 years of Enterprise Value data on record, last reported at -$8.3 million in Q3 2025.

  • For Q3 2025, Enterprise Value rose 85.28% year-over-year to -$8.3 million; the TTM value through Sep 2025 reached -$8.3 million, up 85.28%, while the annual FY2024 figure was -$49.0 million, 56.0% up from the prior year.
  • Enterprise Value reached -$8.3 million in Q3 2025 per BCAB's latest filing, up from -$18.2 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$100000.0 in Q3 2023 and bottomed at -$269.9 million in Q3 2021.
  • Average Enterprise Value over 5 years is -$129.1 million, with a median of -$140.1 million recorded in 2023.
  • Peak YoY movement for Enterprise Value: crashed 112730.98% in 2021, then soared 99.94% in 2023.
  • A 5-year view of Enterprise Value shows it stood at -$245.0 million in 2021, then grew by 27.29% to -$178.1 million in 2022, then surged by 37.42% to -$111.5 million in 2023, then soared by 56.0% to -$49.0 million in 2024, then surged by 83.04% to -$8.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$8.3 million in Q3 2025, -$18.2 million in Q2 2025, and -$32.4 million in Q1 2025.